Titre : Formocrésol

Formocrésol : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Formocrésol : Questions médicales les plus fréquentes", "headline": "Formocrésol : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Formocrésol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-07", "dateModified": "2025-03-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Formocrésol" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Crésols", "url": "https://questionsmedicales.fr/mesh/D003408", "about": { "@type": "MedicalCondition", "name": "Crésols", "code": { "@type": "MedicalCode", "code": "D003408", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.657.239" } } }, "about": { "@type": "MedicalCondition", "name": "Formocrésol", "alternateName": "Formocresols", "code": { "@type": "MedicalCode", "code": "D005566", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rakhi Issrani", "url": "https://questionsmedicales.fr/author/Rakhi%20Issrani", "affiliation": { "@type": "Organization", "name": "Department of Preventive Dentistry, College of Dentistry, Jouf University, 72388 Sakaka, Saudi Arabia." } }, { "@type": "Person", "name": "Namdeo Prabhu", "url": "https://questionsmedicales.fr/author/Namdeo%20Prabhu", "affiliation": { "@type": "Organization", "name": "Department of Oral & Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, 72388 Sakaka, Saudi Arabia." } }, { "@type": "Person", "name": "Kumar Abirami", "url": "https://questionsmedicales.fr/author/Kumar%20Abirami", "affiliation": { "@type": "Organization", "name": "Department of Pedodontics, SRM Dental College, Chennai, Tamil Nadu, India." } }, { "@type": "Person", "name": "Hemalatha Ramkumar", "url": "https://questionsmedicales.fr/author/Hemalatha%20Ramkumar", "affiliation": { "@type": "Organization", "name": "Department of Pedodontics and Preventive Dentistry, SRM Dental College, Chennai, Tamil Nadu, India." } }, { "@type": "Person", "name": "Dakshinamurthy Senthil", "url": "https://questionsmedicales.fr/author/Dakshinamurthy%20Senthil", "affiliation": { "@type": "Organization", "name": "Department of Pedodontics and Preventive Dentistry, Chettinad Dental College and Research Institute, Kanchipuram, Tamil Nadu, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36582571", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.31958" } }, { "@type": "ScholarlyArticle", "name": "Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36620166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21037/qims-22-234" } }, { "@type": "ScholarlyArticle", "name": "Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.", "datePublished": "2022-11-07", "url": "https://questionsmedicales.fr/article/36315465", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/rcs.2477" } }, { "@type": "ScholarlyArticle", "name": "Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36479600", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4048/jbc.2022.25.e44" } }, { "@type": "ScholarlyArticle", "name": "Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36153587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12957-022-02766-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénols", "item": "https://questionsmedicales.fr/mesh/D010636" }, { "@type": "ListItem", "position": 8, "name": "Crésols", "item": "https://questionsmedicales.fr/mesh/D003408" }, { "@type": "ListItem", "position": 9, "name": "Formocrésol", "item": "https://questionsmedicales.fr/mesh/D005566" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Formocrésol - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Formocrésol", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Formocrésol", "description": "Comment le formocrésol est-il utilisé en diagnostic dentaire ?\nQuels tests sont effectués avant l'utilisation du formocrésol ?\nLe formocrésol est-il utilisé pour diagnostiquer des maladies ?\nQuels signes indiquent l'utilisation du formocrésol ?\nLe formocrésol est-il utilisé dans d'autres spécialités médicales ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Formocrésol", "description": "Quels symptômes nécessitent l'utilisation de formocrésol ?\nLe formocrésol peut-il provoquer des effets secondaires ?\nQuels signes d'infection sont traités par formocrésol ?\nLe formocrésol soulage-t-il la douleur immédiatement ?\nQuels symptômes indiquent une réaction au formocrésol ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Formocrésol", "description": "Comment prévenir les infections dentaires ?\nLe formocrésol peut-il être utilisé préventivement ?\nQuels conseils pour éviter les douleurs dentaires ?\nLes visites dentaires régulières aident-elles à prévenir les infections ?\nLes scellants dentaires aident-ils à prévenir les caries ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Formocrésol", "description": "Comment le formocrésol est-il administré ?\nLe formocrésol est-il efficace contre toutes les infections dentaires ?\nCombien de temps le traitement au formocrésol dure-t-il ?\nLe formocrésol nécessite-t-il des soins post-traitement ?\nPeut-on combiner le formocrésol avec d'autres traitements ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Formocrésol", "description": "Quelles complications peuvent survenir avec le formocrésol ?\nLe formocrésol peut-il causer des dommages aux tissus ?\nComment gérer une réaction au formocrésol ?\nLe formocrésol peut-il entraîner des infections secondaires ?\nQuels signes indiquent une complication après traitement ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Formocrésol", "description": "Quels facteurs augmentent le risque d'infection dentaire ?\nLes personnes âgées sont-elles plus à risque ?\nLe tabagisme influence-t-il le risque d'infections dentaires ?\nLes maladies chroniques augmentent-elles le risque d'infections ?\nUne alimentation déséquilibrée est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D005566?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le formocrésol est-il utilisé en diagnostic dentaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il est utilisé pour traiter les infections pulpaire et comme agent de désinfection." } }, { "@type": "Question", "name": "Quels tests sont effectués avant l'utilisation du formocrésol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'allergie et d'évaluation de la santé dentaire sont réalisés." } }, { "@type": "Question", "name": "Le formocrésol est-il utilisé pour diagnostiquer des maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est principalement utilisé pour le traitement, pas pour le diagnostic." } }, { "@type": "Question", "name": "Quels signes indiquent l'utilisation du formocrésol ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes d'infection ou de nécrose pulpaire peuvent justifier son utilisation." } }, { "@type": "Question", "name": "Le formocrésol est-il utilisé dans d'autres spécialités médicales ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Principalement en dentisterie, son usage est limité dans d'autres spécialités." } }, { "@type": "Question", "name": "Quels symptômes nécessitent l'utilisation de formocrésol ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleur dentaire, gonflement et sensibilité au chaud ou au froid." } }, { "@type": "Question", "name": "Le formocrésol peut-il provoquer des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques ou des irritations peuvent survenir." } }, { "@type": "Question", "name": "Quels signes d'infection sont traités par formocrésol ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, gonflement et pus autour de la dent affectée." } }, { "@type": "Question", "name": "Le formocrésol soulage-t-il la douleur immédiatement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut réduire la douleur, mais un soulagement complet peut prendre du temps." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction au formocrésol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Démangeaisons, rougeurs ou gonflements au site d'application." } }, { "@type": "Question", "name": "Comment prévenir les infections dentaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste." } }, { "@type": "Question", "name": "Le formocrésol peut-il être utilisé préventivement ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est utilisé pour traiter des infections déjà présentes." } }, { "@type": "Question", "name": "Quels conseils pour éviter les douleurs dentaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments sucrés, se brosser les dents régulièrement et utiliser du fil dentaire." } }, { "@type": "Question", "name": "Les visites dentaires régulières aident-elles à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de détecter et traiter les problèmes précocement." } }, { "@type": "Question", "name": "Les scellants dentaires aident-ils à prévenir les caries ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils protègent les dents contre les caries et les infections." } }, { "@type": "Question", "name": "Comment le formocrésol est-il administré ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement appliqué directement sur la dent affectée par un dentiste." } }, { "@type": "Question", "name": "Le formocrésol est-il efficace contre toutes les infections dentaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il est efficace contre de nombreuses infections, mais pas toutes." } }, { "@type": "Question", "name": "Combien de temps le traitement au formocrésol dure-t-il ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut durer plusieurs semaines, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Le formocrésol nécessite-t-il des soins post-traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés et des suivis sont nécessaires après le traitement." } }, { "@type": "Question", "name": "Peut-on combiner le formocrésol avec d'autres traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être utilisé avec d'autres traitements dentaires selon les besoins." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le formocrésol ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques, des irritations ou des échecs de traitement peuvent survenir." } }, { "@type": "Question", "name": "Le formocrésol peut-il causer des dommages aux tissus ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une utilisation incorrecte peut endommager les tissus environnants." } }, { "@type": "Question", "name": "Comment gérer une réaction au formocrésol ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un médecin pour évaluer la réaction et ajuster le traitement." } }, { "@type": "Question", "name": "Le formocrésol peut-il entraîner des infections secondaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise application peut favoriser des infections secondaires." } }, { "@type": "Question", "name": "Quels signes indiquent une complication après traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, douleur persistante ou gonflement au site de traitement." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infection dentaire ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Mauvaise hygiène bucco-dentaire, caries non traitées et maladies systémiques." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent avoir des dents plus fragiles et des problèmes de santé associés." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque d'infections dentaires ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme nuit à la santé bucco-dentaire et augmente le risque d'infections." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque d'infections ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent affaiblir le système immunitaire." } }, { "@type": "Question", "name": "Une alimentation déséquilibrée est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en sucres et pauvre en nutriments favorise les caries." } } ] } ] }

Sources (10000 au total)

Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.

Bowel cancer is the fourth most common type of cancer in the United Kingdom in 2019. Total mesorectal excision is the standard procedure for the removal of rectal tumors, however, it comes with seriou... During a five-year period, 42 patients underwent TAMIS at Cumberland Infirmary. The primary indication for TAMIS was distal rectal lesions, large rectal polyps up to 120 mm, and early rectal cancer (T... Our findings suggest that TAMIS produces positive results. The size of the lesions removed, and the effect of an early learning curve are reflected in the rate of specimen fragmentation and polyp recu...

Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.

In the post-Z0011 era, sentinel lymph node (SLN) status and metastatic burden determine whether axillary management entails conservative sentinel lymph node biopsy (SLNB) or radical axillary lymph nod... A retrospective study was conducted on 88 consecutive patients who were diagnosed with clinical T1-2N0 breast cancer between December 2020 and November 2021 at the Lanzhou University Second Hospital a... CEUS successfully identified at least 1 SLN in 88 patients, with a total of 118 SLNs identified in the entire cohort. Univariate analysis showed that lesion size, blood flow grade, SLN longitudinal di... The contrast-enhanced pattern of the SLN is an independent risk factor for SLN status. Patients presenting with a type I or type II SLN enhanced pattern are unlikely to have high-burden metastases det...

Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.

Minimally invasive surgery (MIS) techniques, currently considered the gold standard in the treatment of early-stage non-small cell lung cancer (NSCLC), are mainly represented by video-assisted thoraco... U-RATS was conducted through a single 4 cm long antero-lateral mini-thoracotomy (ALMT) in the sixth intercostal space at the mid-axillary line. Three 8 mm robotic trocars were positioned and connected... Case 1: an 82-year-old woman (American Society of Anaesthesiologists [ASA III]) underwent a left S6 segmentectomy for a clinical stage IA2 NSCLC, complicated by an air leak that resolved spontaneously... From what emerged in our small series, U-RATS with the Da Vinci Xi surgical system might be considered a safe, reliable, and effective alternative to other MIS techniques. Larger prospective studies a...

Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis.

Pylorus-preserving gastrectomy (PPG) is a function-preserving surgery for the treatment of early gastric cancer (EGC) in the middle third of the stomach. According to the literature reports, PPG decre... The protocol was registered in PROSPERO under number CRD42022304677. Databases including PubMed, Embase, Web of Science, and the Cochrane Register of Controlled Trials were searched before February 21... A total of 4500 patients from 16 studies were included. Compared with the CDG group, the PPG group had fewer lymph nodes harvested (WMD= -3.09; 95% CI -4.75 to -1.43; P < 0.001). Differences in the nu... The meta-analysis of existing evidence demonstrated that the survival outcomes of PPG may be comparable to those of CDG. However, fewer lymph nodes at stations in No. 5, No. 6, No. 9, and No. 11p were...

Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.

The sensitivity and specificity of current biomarkers for gastric cancer were insufficient. The aim of the present study was to screen novel biomarkers and determine the diagnostic values of ornithine... With stable isotope tags, we labelled an initial discovery group of four paired gastric cancer tissue samples and identified with LC-ESI-MS/MS. A validation group of 159 gastric cancer samples and 30 ... Four hundred and thirty one proteins were found differentially expressed in gastric cancer tissues. Of these proteins, OAT and CPS1 were found over-expressed in gastric cancer patients, with sensitivi... The present findings indicated a tight correlation between the co-expression of OAT and CPS1 and the histological grade, local invasion, and TNM stages of gastric cancer. Therefore, OAT and CPS1 might...

Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer.

Among women with early-stage endometrial cancer (EC), age, stage, grade, and histology are used to determine fitness for adjuvant radiation therapy (RT) administration. We examined non-cancer factors ... Using data from the Surveillance Epidemiology and End Results cancer registry program linked with Medicare claims, we identified 25,654 women (aged ≥66 years) diagnosed with first primary stage I-II E... Adjuvant RT was less commonly administered to Asian American and Pacific Islander patients than non-Hispanic White patients (Prevalence ratio [PR], 0.84; 95% confidence interval [CI], 0.73 to 0.97). C... Findings suggest that various non-cancer factors affect the delivery of adjuvant RT to older women with early-stage EC in real-world oncology practice. Advancing our understanding of factors associate...

Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer.

Treatment for metastatic colorectal cancer patients beyond the second line remains challenging, highlighting the need for early phase trials of combination therapies for patients who had disease progr... MORPHEUS-CRC is an umbrella, multicenter, open-label, phase Ib/II, randomized, controlled trial (NCT03555149), with active experimental arms ongoing. Patients enrolled were assigned to a control arm (... The experimental arm showed no efficacy signal, yet a well-tolerated safety profile in the MORPHEUS-CRC trial. Treatment effects estimated in hybrid control design were comparable to those in the MORP... Hybrid control provides comparable treatment-effect estimates with generally improved precision, and thus can be of value to inform early-phase clinical development in metastatic colorectal cancer....

Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.

Early biochemical recurrence (eBCR) indicated a high risk for potential recurrence and metastasis in prostate cancer. The N6-methyladenosine (m6A) methylation modification played an important role in ... Pearson correlation analysis was first conducted to explore m6A lncRNAs and univariate Cox regression analysis was further performed to identify m6A lncRNAs of prognostic roles for predicting eBCR in ... Five hundred and thirty-eighth m6A lncRNAs were searched out through Pearson correlation analysis and 25 out of 538 m6A lncRNAs were identified to pose prediction roles for eBCR in prostate cancers. A... The m6A lncRNA signature in this study could be utilized to efficiently predict eBCR occurrence, various clinical characteristic and immune microenvironment for prostate cancer....